Figure S1 from Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases | Synapse
April 3, 2024Open Access
Figure S1 from Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
Key Points
Key points are not available for this paper at this time.
Abstract
Supplemental Figure 1. Myddosome signaling in normal human cerebral cortex.